Page last updated: 2024-09-04

naproxen and Cardiovascular Stroke

naproxen has been researched along with Cardiovascular Stroke in 52 studies

Research

Studies (52)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (3.85)	18.7374
1990's	1 (1.92)	18.2507
2000's	37 (71.15)	29.6817
2010's	7 (13.46)	24.3611
2020's	5 (9.62)	2.80

Authors

Authors	Studies
Bonnesen, K; Ehrenstein, V; Grønkjær, MS; Hallas, J; Lash, TL; Pedersen, L; Schmidt, M; Sørensen, HT	1
Bonnesen, K; Ehrenstein, V; Lash, TL; Pedersen, L; Schmidt, M; Sørensen, HT	1
Ernst, MT; Hallas, J; Pottegård, A; Schmidt, M	1
Choi, HK; Dubreuil, M; LaRochelle, MR; Lei, G; Lin, J; Lu, N; Tomasson, G; Wei, J; Wood, MJ; Zeng, C; Zhang, Y	1
Devane, D; Jordan, F; Kelly, JP; McGuinness, B; Murphy, K; Passmore, P; Quinn, TJ; Tudur Smith, C	1
Choi, HK; Dubreuil, M; Louie-Gao, Q; Neogi, T; Peloquin, CE; Zhang, Y	1
Abramson, S; Arber, N; Baigent, C; Baron, JA; Bhala, N; Bombardier, C; Cannon, C; Emberson, J; Farkouh, ME; FitzGerald, GA; Goss, P; Halls, H; Hawk, E; Hawkey, C; Hennekens, C; Hochberg, M; Holland, LE; Kearney, PM; Laine, L; Lanas, A; Lance, P; Laupacis, A; Merhi, A; Oates, J; Patrono, C; Schnitzer, TJ; Solomon, S; Tugwell, P; Wilson, K; Wittes, J	1
Leufkens, HG; Rietbrock, S; Setakis, E; van Staa, TP	1
Banerjee, S; Brilakis, ES; Cryer, B; Cunningham, F; Harford, WV; Kazi, S; Kelly, KC; Little, BB; Warner, JJ; Weideman, RA	1
Li, L	1
Arbogast, PG; Castellsague, J; Chung, CP; Daugherty, JR; García-Rodríguez, LA; Murray, KT; Ray, WA; Stein, CM; Varas-Lorenzo, C	1
Abuzetun, JY; Elder, M; Mooss, A; Satpathy, R; Suker, M	1
Bjerring Olesen, J; Charlot, M; Folke, F; Fosbøl, EL; Gislason, GH; Hansen, PR; Køber, L; Lamberts, M; Lindhardsen, J; Schjerning Olsen, AM; Selmer, C; Torp-Pedersen, C	1
Bavry, AA; Cooper-Dehoff, RM; Gong, Y; Handberg, EM; Khaliq, A; Pepine, CJ	1
Abenhaim, L; Autret-Leca, E; Benichou, J; Bessede, G; Cottin, Y; Danchin, N; Grimaldi-Bensouda, L; Ovize, M; Rossignol, M; Steg, PG	1
Anderson, GM; Austin, PC; Juurlink, DN; Kopp, A; Laupacis, A; Mamdani, M; Naglie, G; Rochon, P	1
Schechter, S	1
Choi, HK; Kuntz, KM; Seeger, JD	1
García Rodríguez, LA; González-Pérez, A; Maguire, A; Varas-Lorenzo, C	1
Berlin, JA; Chittams, J; Jaskowiak, J; Kimmel, SE; Kishel, L; Reilly, M; Strom, BL	1
Lee, RT	1
Waxman, HA	1
Berti, F; Brini, AT; Clement, MG; De Gennaro Colonna, V; Manfredi, B; Polvani, G; Rossoni, G	1
Curfman, GD; Drazen, JM; Morrissey, S	1
Bombardier, C; Burgos-Vargas, R; Davis, B; Day, R; Ferraz, MB; Hawkey, CJ; Hochberg, MC; Kvien, TK; Laine, L; Schnitzer, TJ; Weaver, A	1
Reicin, A; Shapiro, D	1
García Rodríguez, LA; Hernández-Díaz, S; Varas-Lorenzo, C	1
Everitt, S; Gray, D; Hawkey, CJ; Hawkey, GM; Skelly, MM; Stack, WA	1
Smith, R	1
Häussler, B; Höer, A	1
Brookhart, MA; Rassen, J; Schneeweiss, S; Solomon, DH; Wang, PS	1
Atmaca, Y; Erol, C; Gulec, S; Ozdol, C; Rahimov, U; Turhan, S	1
Nedjar, H; Rahme, E	1
Ashcroft, DM; Chen, LC	1
Andrade, SE; Boudreau, D; Brown, JS; Chan, KA; Davis, RL; Graham, D; Gunter, MJ; Gurwitz, JH; Herrinton, L; Kulldorff, M; Pettus, PT; Platt, R; Raebel, MA; Roblin, D; Smith, D	1
Borzak, S; Hennekens, CH	1
Blum, D; Cunnington, M; Funk, MJ; Mander, A; Qizilbash, N; Webb, D; Weil, J	1
Bolli, R; Davenport, N; Epstein, SE; Goldstein, RE	1
Jick, SS	1
Verheugt, FW	1
Daugherty, JR; Griffin, MR; Hall, K; Ray, WA; Stein, CM	1
Vane, JR	1
Frankish, H	1
Dalen, JE	1
Avorn, J; Glynn, RJ; Levin, R; Solomon, DH	1
LeLorier, J; Pilote, L; Rahme, E	1
Cai, B; Guess, HA; Rhodes, T; Watson, DJ	1
Bala, T	1
Bayés de Luna, A; Cisteró, A; Garcia-Moll, M; Geli, A; Guindo, J; Lleonart, R; Urías, S	1

Reviews

5 review(s) available for naproxen and Cardiovascular Stroke

Article	Year
Aspirin and other non-steroidal anti-inflammatory drugs for the prevention of dementia. The Cochrane database of systematic reviews, 2020, 04-30, Volume: 4 Topics: Activities of Daily Living; Adult; Aged; Aged, 80 and over; Alzheimer Disease; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Celecoxib; Cyclooxygenase 2 Inhibitors; Dementia; Hemorrhage; Humans; Incidence; Lactones; Middle Aged; Myocardial Infarction; Naproxen; Randomized Controlled Trials as Topic; Stroke; Sulfones	2020
Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. Lancet (London, England), 2013, Aug-31, Volume: 382, Issue:9894 Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Vessels; Coronary Disease; Cyclooxygenase 2 Inhibitors; Diclofenac; Gastrointestinal Diseases; Gastrointestinal Tract; Humans; Ibuprofen; Myocardial Infarction; Naproxen; Stroke; Vascular Diseases	2013
Non-steroidal antiinflammatory drugs and the risk of acute myocardial infarction. Basic & clinical pharmacology & toxicology, 2006, Volume: 98, Issue:3 Topics: Anti-Inflammatory Agents, Non-Steroidal; Case-Control Studies; Cohort Studies; Diclofenac; Dose-Response Relationship, Drug; Humans; Ibuprofen; Lactones; Myocardial Infarction; Naproxen; Risk Factors; Sulfones	2006
Risk of myocardial infarction associated with selective COX-2 inhibitors: meta-analysis of randomised controlled trials. Pharmacoepidemiology and drug safety, 2007, Volume: 16, Issue:7 Topics: Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cyclooxygenase 2 Inhibitors; Diclofenac; Dose-Response Relationship, Drug; Etoricoxib; Humans; Isoxazoles; Lactones; Models, Statistical; Myocardial Infarction; Naproxen; Odds Ratio; Pyrazoles; Pyridines; Randomized Controlled Trials as Topic; Risk; Risk Factors; Sulfonamides; Sulfones	2007
Selective COX-2 Inhibitors, NSAIDs, aspirin, and myocardial infarction. Archives of internal medicine, 2002, May-27, Volume: 162, Issue:10 Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cyclooxygenase Inhibitors; Humans; Myocardial Infarction; Naproxen	2002

Trials

1 trial(s) available for naproxen and Cardiovascular Stroke

Article	Year
Naproxen treatment prevents periprocedural inflammatory response but not myocardial injury after percutaneous coronary intervention. Thrombosis research, 2007, Volume: 119, Issue:4 Topics: Aged; Angioplasty, Balloon, Coronary; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; C-Reactive Protein; Clopidogrel; Creatine Kinase, MB Form; Drug Combinations; Female; Follow-Up Studies; Humans; Inflammation; Intraoperative Period; Male; Middle Aged; Myocardial Infarction; Naproxen; Platelet Aggregation Inhibitors; Ticlopidine; Time Factors; Treatment Outcome; Troponin I	2007

Article

Year

Naproxen treatment prevents periprocedural inflammatory response but not myocardial injury after percutaneous coronary intervention.

Thrombosis research, 2007, Volume: 119, Issue:4

Topics: Aged; Angioplasty, Balloon, Coronary; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; C-Reactive Protein; Clopidogrel; Creatine Kinase, MB Form; Drug Combinations; Female; Follow-Up Studies; Humans; Inflammation; Intraoperative Period; Male; Middle Aged; Myocardial Infarction; Naproxen; Platelet Aggregation Inhibitors; Ticlopidine; Time Factors; Treatment Outcome; Troponin I

2007

Other Studies

46 other study(ies) available for naproxen and Cardiovascular Stroke

Article	Year
Impact of Lifestyle and Socioeconomic Position on the Association Between Non-steroidal Anti-inflammatory Drug Use and Major Adverse Cardiovascular Events: A Case-Crossover Study. Drug safety, 2023, Volume: 46, Issue:6 Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Cardiovascular Diseases; Cross-Over Studies; Diclofenac; Humans; Ibuprofen; Life Style; Myocardial Infarction; Naproxen; Risk Factors; Socioeconomic Factors	2023
Impact of hemoglobin A1c level on the association between non-steroidal anti-inflammatory drug use and cardiovascular events in patients with type 2 diabetes: A population-based cohort study. Pharmacoepidemiology and drug safety, 2023, Volume: 32, Issue:11 Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Cohort Studies; Diabetes Mellitus, Type 2; Diclofenac; Glycated Hemoglobin; Humans; Ibuprofen; Myocardial Infarction; Naproxen; Risk Factors	2023
Cardiovascular risks of continuing vs. initiating NSAIDs after first-time myocardial infarction or heart failure: a nationwide cohort study. European heart journal. Cardiovascular pharmacotherapy, 2023, 09-20, Volume: 9, Issue:6 Topics: Anti-Inflammatory Agents, Non-Steroidal; Cardiovascular Diseases; Cohort Studies; Diclofenac; Heart Disease Risk Factors; Heart Failure; Humans; Ibuprofen; Myocardial Infarction; Naproxen; Risk Factors	2023
Association of tramadol with risk of myocardial infarction among patients with osteoarthritis. Osteoarthritis and cartilage, 2020, Volume: 28, Issue:2 Topics: Aged; Aged, 80 and over; Analgesics, Opioid; Anti-Inflammatory Agents, Non-Steroidal; Codeine; Diclofenac; Female; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Naproxen; Osteoarthritis; Propensity Score; Proportional Hazards Models; Risk Factors; Tramadol	2020
Risk of myocardial infarction with use of selected non-steroidal anti-inflammatory drugs in patients with spondyloarthritis and osteoarthritis. Annals of the rheumatic diseases, 2018, Volume: 77, Issue:8 Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Case-Control Studies; Diclofenac; Female; Humans; Male; Middle Aged; Myocardial Infarction; Naproxen; Osteoarthritis; Risk Assessment; Sensitivity and Specificity; Severity of Illness Index; Spondylarthritis; Young Adult	2018
Pain relievers: bad for your heart? People with heart disease should avoid prolonged use of certain anti-inflammatory drugs, Naproxen (Aleve) is safest. Harvard men's health watch, 2013, Volume: 17, Issue:6 Topics: Anti-Inflammatory Agents, Non-Steroidal; Health Behavior; Heart; Heart Failure; Humans; Myocardial Infarction; Naproxen	2013
Does the varied use of NSAIDs explain the differences in the risk of myocardial infarction? Journal of internal medicine, 2008, Volume: 264, Issue:5 Topics: Adult; Age Factors; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Drug Administration Schedule; Epidemiologic Methods; Female; Humans; Ibuprofen; Male; Middle Aged; Myocardial Infarction; Naproxen; Sex Factors; Time Factors	2008
The risk of acute myocardial infarction with etodolac is not increased compared to naproxen: a historical cohort analysis of a generic COX-2 selective inhibitor. Journal of cardiovascular pharmacology and therapeutics, 2008, Volume: 13, Issue:4 Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cohort Studies; Cyclooxygenase 2 Inhibitors; Drug Utilization Review; Drugs, Generic; Etodolac; Humans; Incidence; Lactones; Male; Medical Records; Middle Aged; Myocardial Infarction; Naproxen; Prevalence; Prognosis; Pyrazoles; Retrospective Studies; Risk Assessment; Risk Factors; Sulfonamides; Sulfones; Texas; Veterans	2008
A conditional sequential sampling procedure for drug safety surveillance. Statistics in medicine, 2009, Nov-10, Volume: 28, Issue:25 Topics: Aged; Computer Simulation; Cyclooxygenase 2 Inhibitors; Diclofenac; Drug Evaluation; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Lactones; Male; Middle Aged; Myocardial Infarction; Naproxen; Product Surveillance, Postmarketing; Risk; Sulfones	2009
Cardiovascular risks of nonsteroidal antiinflammatory drugs in patients after hospitalization for serious coronary heart disease. Circulation. Cardiovascular quality and outcomes, 2009, Volume: 2, Issue:3 Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Cardiovascular Diseases; Celecoxib; Cohort Studies; Coronary Artery Disease; Cyclooxygenase 2 Inhibitors; Diclofenac; Female; Follow-Up Studies; Hospitalization; Humans; Ibuprofen; Incidence; Lactones; Male; Middle Aged; Myocardial Infarction; Naproxen; Outpatients; Pyrazoles; Retrospective Studies; Risk Factors; Stroke; Sulfonamides; Sulfones; Tennessee	2009
Naproxen-induced ST-elevation myocardial infarction in a 33-year-old man. Journal of cardiovascular medicine (Hagerstown, Md.), 2012, Volume: 13, Issue:7 Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase Inhibitors; Drug Eruptions; Drug Hypersensitivity; Electrocardiography; Humans; Male; Myocardial Infarction; Naproxen	2012
Duration of treatment with nonsteroidal anti-inflammatory drugs and impact on risk of death and recurrent myocardial infarction in patients with prior myocardial infarction: a nationwide cohort study. Circulation, 2011, May-24, Volume: 123, Issue:20 Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Cohort Studies; Comorbidity; Contraindications; Cyclooxygenase 2 Inhibitors; Denmark; Diclofenac; Female; Humans; Ibuprofen; Incidence; Male; Middle Aged; Myocardial Infarction; Naproxen; Prognosis; Proportional Hazards Models; Recurrence; Registries; Risk Factors	2011
Harmful effects of NSAIDs among patients with hypertension and coronary artery disease. The American journal of medicine, 2011, Volume: 124, Issue:7 Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; Blood Pressure; Celecoxib; Confounding Factors, Epidemiologic; Coronary Artery Disease; Diclofenac; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Hypertension; Ibuprofen; Indoles; Kaplan-Meier Estimate; Male; Middle Aged; Multicenter Studies as Topic; Multivariate Analysis; Myocardial Infarction; Naproxen; Odds Ratio; Proportional Hazards Models; Pyrazoles; Randomized Controlled Trials as Topic; Stroke; Sulfonamides; Verapamil	2011
Risk of ST versus non-ST elevation myocardial infarction associated with non-steroidal anti-inflammatory drugs. Heart (British Cardiac Society), 2011, Volume: 97, Issue:22 Topics: Adolescent; Adult; Aged; Algorithms; Anti-Inflammatory Agents, Non-Steroidal; Case-Control Studies; Diclofenac; Drug Therapy, Combination; Electrocardiography; Female; France; Heart Conduction System; Humans; Logistic Models; Male; Middle Aged; Myocardial Infarction; Naproxen; Odds Ratio; Risk Assessment; Risk Factors; Treatment Outcome	2011
Effect of selective cyclooxygenase 2 inhibitors and naproxen on short-term risk of acute myocardial infarction in the elderly. Archives of internal medicine, 2003, Feb-24, Volume: 163, Issue:4 Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Case-Control Studies; Celecoxib; Cyclooxygenase Inhibitors; Female; Humans; Lactones; Male; Myocardial Infarction; Naproxen; Ontario; Proportional Hazards Models; Pyrazoles; Retrospective Studies; Risk Factors; Sulfonamides; Sulfones	2003
Naproxen's interaction with aspirin may affect its cardioprotective effect. Archives of internal medicine, 2003, Jun-09, Volume: 163, Issue:11 Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cyclooxygenase Inhibitors; Drug Synergism; Drug Therapy, Combination; Humans; Myocardial Infarction; Naproxen	2003
Effects of rofecoxib and naproxen on life expectancy among patients with rheumatoid arthritis: a decision analysis. The American journal of medicine, 2004, May-01, Volume: 116, Issue:9 Topics: Aged; Arthritis, Rheumatoid; Cyclooxygenase Inhibitors; Decision Support Techniques; Female; Gastrointestinal Diseases; Humans; Lactones; Life Expectancy; Male; Middle Aged; Myocardial Infarction; Naproxen; Quality of Life; Sulfones; Time Factors	2004
Nonsteroidal antiinflammatory drugs and the risk of myocardial infarction in the general population. Circulation, 2004, Jun-22, Volume: 109, Issue:24 Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cardiotonic Agents; Case-Control Studies; Cohort Studies; Comorbidity; Coronary Disease; Cyclooxygenase Inhibitors; Diclofenac; Dose-Response Relationship, Drug; Drug Synergism; Drug Utilization; Female; Follow-Up Studies; Humans; Ibuprofen; Lactones; Male; Middle Aged; Myocardial Infarction; Naproxen; Odds Ratio; Risk Factors; Spain; Sulfones	2004
Patients exposed to rofecoxib and celecoxib have different odds of nonfatal myocardial infarction. Annals of internal medicine, 2005, Feb-01, Volume: 142, Issue:3 Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Bias; Case-Control Studies; Celecoxib; Confounding Factors, Epidemiologic; Cyclooxygenase Inhibitors; Diclofenac; Female; Humans; Ibuprofen; Lactones; Male; Middle Aged; Myocardial Infarction; Naproxen; Odds Ratio; Pyrazoles; Risk Factors; Sulfonamides; Sulfones	2005
Ask the doctor. I am a 60-year-old man with several risk factors for heart disease. I take Aleve twice a day. Do I still need to take aspirin, or is the Aleve enough? I often take ibuprofen for my headaches or aching back. Now my doctor wants me to start Harvard heart letter : from Harvard Medical School, 2005, Volume: 15, Issue:6 Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cyclooxygenase Inhibitors; Drug Interactions; Humans; Ibuprofen; Male; Middle Aged; Myocardial Infarction; Naproxen	2005
The lessons of Vioxx--drug safety and sales. The New England journal of medicine, 2005, Jun-23, Volume: 352, Issue:25 Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Cyclooxygenase Inhibitors; Drug Evaluation; Drug Industry; Gastrointestinal Diseases; Humans; Lactones; Marketing; Myocardial Infarction; Naproxen; Scientific Misconduct; Sulfones; United States	2005
[Study results of routine clinical practice. Do rheumatism patients get substandard care?]. MMW Fortschritte der Medizin, 2005, Nov-24, Volume: 147, Issue:47 Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cyclooxygenase 2 Inhibitors; Germany; Humans; Ibuprofen; Myocardial Infarction; Naproxen; Peptic Ulcer; Quality Assurance, Health Care; Retrospective Studies; Risk Assessment; Risk Factors	2005
Nitric oxide and prostacyclin pathways: an integrated mechanism that limits myocardial infarction progression in anaesthetized rats. Pharmacological research, 2006, Volume: 53, Issue:4 Topics: Animals; Arginine; Arrhythmias, Cardiac; Cardiotonic Agents; Creatine Kinase; Epoprostenol; Isosorbide Dinitrate; Male; Myocardial Infarction; Myocardial Reperfusion; Myocardium; Naproxen; Nitric Oxide; Peroxidase; Polydeoxyribonucleotides; Random Allocation; Rats; Rats, Wistar; Thromboxane B2	2006
Expression of concern reaffirmed. The New England journal of medicine, 2006, Mar-16, Volume: 354, Issue:11 Topics: Arthritis, Rheumatoid; Cardiovascular Diseases; Gastrointestinal Diseases; Humans; Lactones; Myocardial Infarction; Naproxen; Research Design; Sulfones; Thromboembolism	2006
Response to expression of concern regarding VIGOR study. The New England journal of medicine, 2006, Mar-16, Volume: 354, Issue:11 Topics: Arthritis, Rheumatoid; Cardiovascular Diseases; Data Interpretation, Statistical; Gastrointestinal Diseases; Humans; Lactones; Myocardial Infarction; Naproxen; Sulfones	2006
Response to expression of concern regarding VIGOR study. The New England journal of medicine, 2006, Mar-16, Volume: 354, Issue:11 Topics: Arthritis, Rheumatoid; Data Interpretation, Statistical; Gastrointestinal Diseases; Humans; Lactones; Myocardial Infarction; Naproxen; Risk; Sulfones	2006
Increased risk of myocardial infarction as first manifestation of ischaemic heart disease and nonselective nonsteroidal anti-inflammatory drugs. British journal of clinical pharmacology, 2006, Volume: 61, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Case-Control Studies; Cyclooxygenase 2 Inhibitors; Female; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Naproxen; Prospective Studies; Risk Factors	2006
Lapses at the new England journal of medicine. Journal of the Royal Society of Medicine, 2006, Volume: 99, Issue:8 Topics: Boston; Clinical Trials as Topic; Cyclooxygenase 2 Inhibitors; Drug Industry; Gastrointestinal Diseases; Humans; Interprofessional Relations; Lactones; Myocardial Infarction; Naproxen; Periodicals as Topic; Randomized Controlled Trials as Topic; Sulfones	2006
[Overestimated]. Medizinische Klinik (Munich, Germany : 1983), 2006, Aug-15, Volume: 101, Issue:8 Topics: Anti-Inflammatory Agents, Non-Steroidal; Cardiovascular Diseases; Controlled Clinical Trials as Topic; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Humans; Lactones; Myocardial Infarction; Naproxen; Odds Ratio; Risk; Risk Assessment; Stroke; Sulfones	2006
Simultaneous assessment of short-term gastrointestinal benefits and cardiovascular risks of selective cyclooxygenase 2 inhibitors and nonselective nonsteroidal antiinflammatory drugs: an instrumental variable analysis. Arthritis and rheumatism, 2006, Volume: 54, Issue:11 Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cyclooxygenase 2 Inhibitors; Diclofenac; Female; Gastrointestinal Diseases; Humans; Ibuprofen; Lactones; Male; Multivariate Analysis; Myocardial Infarction; Naproxen; Pyrazoles; Rheumatic Diseases; Risk Assessment; Risk Factors; Sulfonamides; Sulfones	2006
Risks and benefits of COX-2 inhibitors vs non-selective NSAIDs: does their cardiovascular risk exceed their gastrointestinal benefit? A retrospective cohort study. Rheumatology (Oxford, England), 2007, Volume: 46, Issue:3 Topics: Acetaminophen; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Celecoxib; Cyclooxygenase 2 Inhibitors; Drug Prescriptions; Drug Therapy, Combination; Female; Gastrointestinal Hemorrhage; Hospitalization; Humans; Lactones; Male; Myocardial Infarction; Naproxen; Pyrazoles; Quebec; Retrospective Studies; Risk Assessment; Sulfonamides; Sulfones	2007
Naproxen still rules. DukeMedicine healthnews, 2007, Volume: 13, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase Inhibitors; Humans; Myocardial Infarction; Naproxen	2007
Early detection of adverse drug events within population-based health networks: application of sequential testing methods. Pharmacoepidemiology and drug safety, 2007, Volume: 16, Issue:12 Topics: Adverse Drug Reaction Reporting Systems; Algorithms; Celecoxib; Competitive Medical Plans; Health Maintenance Organizations; Humans; Insurance Claim Review; Lactones; Medical Records Systems, Computerized; Myocardial Infarction; Naproxen; Population Surveillance; Product Surveillance, Postmarketing; Pyrazoles; Pyridines; Retrospective Studies; Rhabdomyolysis; Sulfonamides; Sulfones; Time Factors; Treatment Outcome; United States	2007
Cyclooxygenase-2 inhibitors and most traditional nonsteroidal anti-inflammatory drugs cause similar moderately increased risks of cardiovascular disease. Journal of cardiovascular pharmacology and therapeutics, 2008, Volume: 13, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Cardiovascular Diseases; Clinical Trials as Topic; Cyclooxygenase 2 Inhibitors; Diclofenac; Dose-Response Relationship, Drug; Humans; Ibuprofen; Meta-Analysis as Topic; Myocardial Infarction; Naproxen; Risk	2008
Risk of ischaemic cardiovascular events from selective cyclooxygenase-2 inhibitors in osteoarthritis. Pharmacoepidemiology and drug safety, 2008, Volume: 17, Issue:6 Topics: Adult; Age Factors; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cohort Studies; Cyclooxygenase 2 Inhibitors; Databases, Factual; Female; Follow-Up Studies; Humans; Isoxazoles; Lactones; Male; Middle Aged; Myocardial Infarction; Naproxen; Osteoarthritis; Proportional Hazards Models; Pyrazoles; Retrospective Studies; Risk Factors; Stroke; Sulfonamides; Sulfones; United States	2008
Influence of sulfinpyrazone and naproxen on infarct size in the dog. The American journal of cardiology, 1981, Volume: 47, Issue:4 Topics: Animals; Constriction, Pathologic; Coronary Vessels; Dogs; Dose-Response Relationship, Drug; Female; Heart Rate; Male; Myocardial Infarction; Myocardium; Naproxen; Platelet Aggregation; Risk; Sulfinpyrazone	1981
The risk of gastrointestinal bleed, myocardial infarction, and newly diagnosed hypertension in users of meloxicam, diclofenac, naproxen, and piroxicam. Pharmacotherapy, 2000, Volume: 20, Issue:7 Topics: Anti-Inflammatory Agents, Non-Steroidal; Case-Control Studies; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Databases, Factual; Diclofenac; Gastrointestinal Hemorrhage; Humans; Hypertension; Isoenzymes; Meloxicam; Membrane Proteins; Myocardial Infarction; Naproxen; Piroxicam; Prostaglandin-Endoperoxide Synthases; Risk Assessment; Thiazines; Thiazoles; United Kingdom	2000
[Safety of specific cyclo-oxygenase 2 inhibitors]. Nederlands tijdschrift voor geneeskunde, 2001, Jul-28, Volume: 145, Issue:30 Topics: Aspirin; Cyclooxygenase Inhibitors; Drug Therapy, Combination; Humans; Myocardial Infarction; Naproxen; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic	2001
Non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease: an observational cohort study. Lancet (London, England), 2002, Jan-12, Volume: 359, Issue:9301 Topics: Age Distribution; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Bias; Cause of Death; Cohort Studies; Coronary Disease; Death Certificates; Drug Prescriptions; Female; Humans; Ibuprofen; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Naproxen; Patient Admission; Platelet Aggregation Inhibitors; Registries; Regression Analysis; Risk Factors; Tennessee	2002
Biomedicine. Back to an aspirin a day? Science (New York, N.Y.), 2002, Apr-19, Volume: 296, Issue:5567 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carotid Artery Injuries; Cell Division; Clinical Trials as Topic; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Epoprostenol; Homeostasis; Humans; Isoenzymes; Lactones; Membrane Proteins; Mice; Muscle, Smooth, Vascular; Myocardial Infarction; Naproxen; Platelet Activation; Prostaglandin-Endoperoxide Synthases; Receptors, Epoprostenol; Receptors, Prostaglandin; Receptors, Thromboxane; Sulfones; Thromboxane A2	2002
Why do COX-2 inhibitors increase risk of cardiovascular events? Lancet (London, England), 2002, Apr-20, Volume: 359, Issue:9315 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Humans; Isoenzymes; Lactones; Membrane Proteins; Mice; Myocardial Infarction; Naproxen; Prostaglandin-Endoperoxide Synthases; Sulfones; Thromboxane A2	2002
Nonsteroidal anti-inflammatory drug use and acute myocardial infarction. Archives of internal medicine, 2002, May-27, Volume: 162, Issue:10 Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Case-Control Studies; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Naproxen; New Jersey; Risk	2002
Association between naproxen use and protection against acute myocardial infarction. Archives of internal medicine, 2002, May-27, Volume: 162, Issue:10 Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Case-Control Studies; Cyclooxygenase Inhibitors; Female; Hospitalization; Humans; Incidence; Male; Matched-Pair Analysis; Myocardial Infarction; Naproxen; Quebec; Risk	2002
Lower risk of thromboembolic cardiovascular events with naproxen among patients with rheumatoid arthritis. Archives of internal medicine, 2002, May-27, Volume: 162, Issue:10 Topics: Adult; Aged; Arthritis, Rheumatoid; Case-Control Studies; England; Humans; Matched-Pair Analysis; Middle Aged; Multivariate Analysis; Myocardial Infarction; Naproxen; Platelet Aggregation Inhibitors; Regression Analysis; Risk; Survival Analysis; Thromboembolism; Wales	2002
[Effect of methoxypropiocin on the dynamics of left ventricular contraction]. Polski tygodnik lekarski (Warsaw, Poland : 1960), 1976, May-17, Volume: 31, Issue:20 Topics: Adult; Aged; Depression, Chemical; Heart Ventricles; Humans; Middle Aged; Myocardial Infarction; Naphthaleneacetic Acids; Naproxen; Rheumatic Diseases	1976
Coronary artery spasm and acute myocardial infarction in naproxen-associated anaphylactic reaction. Allergy, 1992, Volume: 47, Issue:5 Topics: Adult; Anaphylaxis; Coronary Vasospasm; Drug Hypersensitivity; Humans; Male; Myocardial Infarction; Naproxen	1992